These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1084 related items for PubMed ID: 35913161

  • 1. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
    Lesniak NA, Tomkovich S, Henry A, Taylor A, Colovas J, Bishop L, McBride K, Schloss PD.
    mBio; 2022 Aug 30; 13(4):e0136422. PubMed ID: 35913161
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pre-colonization with the commensal fungus Candida albicans reduces murine susceptibility to Clostridium difficile infection.
    Markey L, Shaban L, Green ER, Lemon KP, Mecsas J, Kumamoto CA.
    Gut Microbes; 2018 Nov 02; 9(6):497-509. PubMed ID: 29667487
    [Abstract] [Full Text] [Related]

  • 11. The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model.
    Tomkovich S, Lesniak NA, Li Y, Bishop L, Fitzgerald MJ, Schloss PD.
    mSphere; 2019 Nov 20; 4(6):. PubMed ID: 31748246
    [Abstract] [Full Text] [Related]

  • 12. Gut microbiome and plasma lipidome analysis reveals a specific impact of Clostridioides difficile infection on intestinal bacterial communities and sterol metabolism.
    Arcay R, Barceló-Nicolau M, Suárez L, Martín L, Reigada R, Höring M, Liebisch G, Garrido C, Cabot G, Vílchez H, Cortés-Lara S, González de Herrero E, López-Causapé C, Oliver A, Barceló-Coblijn G, Mena A.
    mBio; 2024 Oct 16; 15(10):e0134724. PubMed ID: 39189787
    [Abstract] [Full Text] [Related]

  • 13. Microbiome Resilience despite a Profound Loss of Minority Microbiota following Clindamycin Challenge in Humanized Gnotobiotic Mice.
    Liu L, Kirst ME, Zhao L, Li E, Wang GP.
    Microbiol Spectr; 2022 Feb 23; 10(1):e0196021. PubMed ID: 35019780
    [Abstract] [Full Text] [Related]

  • 14. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
    Barron MR, Sovacool KL, Abernathy-Close L, Vendrov KC, Standke AK, Bergin IL, Schloss PD, Young VB.
    mBio; 2022 Aug 30; 13(4):e0190422. PubMed ID: 35900107
    [Abstract] [Full Text] [Related]

  • 15. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
    Abernathy-Close L, Barron MR, George JM, Dieterle MG, Vendrov KC, Bergin IL, Young VB.
    mBio; 2021 Jun 29; 12(3):e0273320. PubMed ID: 34126769
    [Abstract] [Full Text] [Related]

  • 16. Inhibiting Growth of Clostridioides difficile by Restoring Valerate, Produced by the Intestinal Microbiota.
    McDonald JAK, Mullish BH, Pechlivanis A, Liu Z, Brignardello J, Kao D, Holmes E, Li JV, Clarke TB, Thursz MR, Marchesi JR.
    Gastroenterology; 2018 Nov 29; 155(5):1495-1507.e15. PubMed ID: 30025704
    [Abstract] [Full Text] [Related]

  • 17. Randomized Controlled Trial of Oral Vancomycin Treatment in Clostridioides difficile-Colonized Patients.
    Fishbein SRS, Hink T, Reske KA, Cass C, Struttmann E, Iqbal ZH, Seiler S, Kwon JH, Burnham CA, Dantas G, Dubberke ER.
    mSphere; 2021 Jan 13; 6(1):. PubMed ID: 33441409
    [Abstract] [Full Text] [Related]

  • 18. Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study.
    Langdon A, Schwartz DJ, Bulow C, Sun X, Hink T, Reske KA, Jones C, Burnham CD, Dubberke ER, Dantas G, CDC Prevention Epicenter Program.
    Genome Med; 2021 Feb 16; 13(1):28. PubMed ID: 33593430
    [Abstract] [Full Text] [Related]

  • 19. Microbiome data distinguish patients with Clostridium difficile infection and non-C. difficile-associated diarrhea from healthy controls.
    Schubert AM, Rogers MA, Ring C, Mogle J, Petrosino JP, Young VB, Aronoff DM, Schloss PD.
    mBio; 2014 May 06; 5(3):e01021-14. PubMed ID: 24803517
    [Abstract] [Full Text] [Related]

  • 20. Characterization of the gut microbiome of patients with Clostridioides difficile infection, patients with non-C. difficile diarrhea, and C. difficile-colonized patients.
    Vázquez-Cuesta S, Villar L, García NL, Fernández AI, Olmedo M, Alcalá L, Marín M, Muñoz P, Bouza E, Reigadas E.
    Front Cell Infect Microbiol; 2023 May 06; 13():1130701. PubMed ID: 37124040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 55.